Back to drug safety directory
GLP-1 receptor agonist (diabetes)Reviewed May 17, 2026

Dulaglutide (Trulicity) and Ketamine Therapy | Tovani Health

Trulicity (Dulaglutide)GLP-1 receptor agonist (diabetes)

Verdict at Tovani Health

Fully compatible; same profile as semaglutide.

Dulaglutide and ketamine have no clinically significant interaction. Same compatibility profile as semaglutide and tirzepatide. Continue as normal.

If you take Trulicity regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.

How Trulicity interacts with ketamine

Dulaglutide is a long-acting GLP-1 receptor agonist administered weekly. No CYP interactions with ketamine.

What we do at intake

Continue as normal. If you have notable GLP-1 nausea, mention it for session-day planning.

Bottom line

Dulaglutide and ketamine have no clinically significant interaction. Same compatibility profile as semaglutide and tirzepatide. Continue as normal.

Ready to find out if at-home ketamine fits your situation?

We’ll note that you’re on Trulicity (Dulaglutide) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.

FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.

Clinically reviewed

Reviewed by Benjamin Soffer, DO on May 17, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.

This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.